Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...
Marijean Buhse, PhD RN NP-C, a clinical associate professor in the School of Nursing at the State University of New York at Stony Brook, Stony Brook, NY.
Fatigue in people with MS has many different manifestations that are unique to each person (Bakshi, 2003). Therefore, when measuring fatigue in the clinical setting, subjective assessments, rather ...
Biogen has said it hopes new “real world” data will ensure patients are not put off taking its key multiple sclerosis drug, Tecfidera because of stomach problems that can occur early in treatment.
Injectable medications for multiple sclerosis (MS) are known as disease-modifying therapies (DMTs). This means they work by slowing or changing the progression of the condition. These are self ...
A 14-week regimen of physical therapy combined with PoNS — a neurostimulator device used to improve mobility — led to significant gait improvements in people with multiple sclerosis (MS), with ...
Researchers don’t yet fully understand what causes multiple sclerosis (MS) but believe it may develop from a combination of genetic and environmental factors. Identifying these factors can help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results